Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HUM
HUM logo

HUM Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
400.000
Open
395.150
VWAP
395.48
Vol
831.10K
Mkt Cap
47.38B
Low
391.820
Amount
328.68M
EV/EBITDA(TTM)
13.56
Total Shares
120.06M
EV
56.27B
EV/OCF(TTM)
30.52
P/S(TTM)
0.35
Humana Inc. provides Humana insurance services and CenterWell health care services. The Company's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.
Show More

Events Timeline

(ET)
2026-06-23
11:00:00
Justice Department to Charge 450 Defendants in $6.5B Healthcare Fraud
select
link
2026-06-17 (ET)
2026-06-17
08:30:00
Humana Selected for Illinois Medicaid Managed Care Program
select
2026-06-11 (ET)
2026-06-11
16:30:00
Stocks Rebound as Retail Investors Submit Over $100B for SpaceX IPO
select
2026-06-11
12:30:00
Major Averages Rebound with Tech Support, Oracle Shares Decline
select
2026-06-11
07:00:00
UnitedHealth and Others Deny 13% of Medical Requests
select
link

News

PRnewswire
7.0
07-03PRnewswire
Halper Sadeh LLC Investigates Humana Executives' Fiduciary Duties
  • Shareholder Rights Protection: Halper Sadeh LLC is investigating whether Humana Inc. executives breached their fiduciary duties, and long-term shareholders may seek corporate governance reforms and fund recovery options.
  • Legal Fee Arrangement: The firm operates on a contingency fee basis, meaning shareholders are not responsible for legal costs, encouraging immediate contact to ensure rights are enforced within time limits.
  • Importance of Shareholder Participation: Involvement from shareholders can enhance company policies and oversight mechanisms, leading to improved transparency and accountability, ultimately increasing shareholder value and effective management.
  • Global Investor Representation: Halper Sadeh LLC represents investors worldwide, focusing on securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered millions for defrauded investors.
seekingalpha
7.5
07-01seekingalpha
Healthcare Sector Q2 Performance Analysis
  • Healthcare Sector Recovery: The healthcare sector rose by 8.22% in Q2, despite concerns over drug pricing and policy uncertainty, outperforming the energy sector and demonstrating relative market resilience.
  • Strong Performance by Insurers: Humana (HUM) was the top performer in Q2, with a stock price increase of over 129%, primarily benefiting from the U.S. government's proposed increase in 2027 Medicare reimbursement, which boosted profitability expectations.
  • Impact of Medical Costs: Centene (CNC) surged over 96% in Q2 after beating Q1 earnings expectations, with the company raising its 2026 adjusted EPS outlook to above $3.40, reflecting the positive impact of lower-than-expected medical costs.
  • Zoetis Underperformance: Zoetis (ZTS) fell more than 39% in Q2 due to growth slowdown and margin reset, highlighting challenges from weak demand in the U.S. companion animal market.
CNBC
6.0
06-30CNBC
Deutsche Bank Optimistic About Q3 Stock Performance
  • Curated Stock List: Deutsche Bank has selected 41 stocks for Q3 across five sectors, including AI, healthcare, and industrials, reflecting confidence in future market performance following a strong first half.
  • Exceptional Investment Returns: Since its inception in Q3 2017, Deutsche Bank's 'Fresh Money' list has achieved a 387% return, significantly outperforming the S&P 500's 351%, indicating the effectiveness of its investment strategy and market insights.
  • Oracle's Promising Outlook: Analyst Brad Zelnick believes Oracle's leadership in AI cloud infrastructure will drive significant growth, despite a 19% drop last week due to financing concerns; with a target price of $300, this implies a 103% upside potential.
  • Starbucks' Significant Potential: Analyst Lauren Silberman notes that Starbucks is on a path to sustainable positive growth by enhancing customer experience and reducing costs, with a target price of $120, suggesting a 15.3% upside from Monday's close, reflecting confidence in its long-term growth prospects.
CNBC
8.5
06-30CNBC
Medicare's New Coverage for Obesity Drugs
  • New Medicare Policy: Starting Wednesday, eligible seniors can access GLP-1 obesity drugs for a $50 monthly copay, a move expected to unlock access for millions of Medicare beneficiaries who previously could not afford such treatments, significantly improving their health outcomes.
  • Potential Patient Pool: Estimates from Novo Nordisk and Eli Lilly suggest that around 15 to 20 million older adults in Medicare qualify for weight loss drugs, presenting a substantial market opportunity for both companies that could drive significant sales growth in the coming years.
  • Implementation Challenges: While the new policy enhances drug accessibility, physicians must submit cumbersome prior authorization requests to certify patient eligibility, which may lead to delays in patients receiving their medications, potentially impacting overall treatment effectiveness.
  • Future Uncertainty: The policy is set to expire at the end of 2027, raising concerns about whether patients will be able to continue their treatments long-term; experts are advocating for legislation to ensure ongoing coverage for obesity drugs to prevent patients from losing access after successful treatment.
CNBC
2.0
06-30CNBC
Nike Shares Plummet, Underperforming in Dow Industrials
  • Nike Stock Decline: Nike shares have fallen nearly 20% over the past three months and are down 48% from the August 2025 high, making it the worst performer in the Dow Industrials, only better than Chevron, indicating significant weakness in its market position.
  • Year-to-Date Performance: Year-to-date, Nike's stock is down about 35%, and no other Dow constituent has performed worse in the past 12 months, highlighting the challenges it faces in the highly competitive sports apparel market.
  • Constellation Brands Struggles: Constellation Brands, the maker of Corona and Modelo beers, has seen its stock drop nearly 8% in the last three months and is down 21% from its July 2025 high, reflecting pressure in its market segment.
  • Healthcare Sector Strength: The healthcare sector has risen nearly 8% in the past month, with Moderna's stock surging 47%, indicating a strong recovery in the sector and investor confidence in its growth potential.
NASDAQ.COM
8.0
06-24NASDAQ.COM
Analysis of HUM Dividend Expectations and Stock Performance
  • Dividend Yield Expectation: HUM's current estimated annualized dividend yield stands at 0.98%, and while dividends are not always predictable, historical data aids in assessing the likelihood of continued dividends, impacting investor return expectations.
  • Stock Price Range: HUM's 52-week low is $163.11 per share, with a high of $380.86, and the latest trade at $364.27 indicates that the stock is fluctuating near its high, which may influence investor buying decisions.
  • ETF Holding Proportion: According to ETF Finder, HUM comprises 34.64% of the AGF U.S. Market Neutral Anti-Beta Fund (BTAL), which is trading down about 0.3% on the day, reflecting overall market sentiment towards HUM.
  • Intraday Stock Performance: In Wednesday trading, Humana Inc. shares are up about 1%, indicating a positive short-term market reaction to the company, which may attract more investor attention.
Wall Street analysts forecast HUM stock price to rise
19 Analyst Rating
Wall Street analysts forecast HUM stock price to rise
6 Buy
12 Hold
1 Sell
Moderate Buy
Current: 0.000
sliders
Low
231.00
Averages
290.39
High
344.00
Current: 0.000
sliders
Low
231.00
Averages
290.39
High
344.00
Cantor Fitzgerald
Sarah James
Neutral
maintain
$264 -> $300
AI Analysis
2026-07-07
New
Reason
Cantor Fitzgerald
Sarah James
Price Target
$264 -> $300
AI Analysis
2026-07-07
New
maintain
Neutral
Reason
Cantor Fitzgerald analyst Sarah James raised the firm's price target on Humana to $300 from $264 and keeps a Neutral rating on the shares. Cantor prefers payors over providers heading into Q2 earnings, supported by management discussions, proprietary checks, and investor conversations, the analyst tells investors in a research note. Payors appear better positioned with continued strength in government insurance lines and VBC opportunities, while provider commentary may struggle to meet elevated expectations, limiting upside despite potential guidance increases, the firm says.
BofA
Neutral
maintain
$340 -> $380
2026-06-24
Reason
BofA
Price Target
$340 -> $380
2026-06-24
maintain
Neutral
Reason
BofA raised the firm's price target on Humana to $380 from $340 and keeps a Neutral rating on the shares. As the firm gets more comfortable with cost trend going into Q2 earnings, it cites a higher multiple for its raised target, but the company's outsized membership growth this year and potential for adverse selection for its Neutral rating.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HUM
Unlock Now

Valuation Metrics

The current forward P/E ratio for Humana Inc (HUM.N) is 43.67, compared to its 5-year average forward P/E of 19.31. For a more detailed relative valuation and DCF analysis to assess Humana Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
19.31
Current PE
43.67
Overvalued PE
23.47
Undervalued PE
15.15

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
10.93
Current EV/EBITDA
6.40
Overvalued EV/EBITDA
14.81
Undervalued EV/EBITDA
7.05

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.44
Current PS
0.28
Overvalued PS
0.61
Undervalued PS
0.26

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

which stocks to buy short term
Intellectia · 40 candidates
Moving Average Relationship: PriceAboveMA20Week Price Change Pct: $4.00 - $12.00Is Index Component: GSPC
Ticker
Name
Market Cap$
top bottom
ELV logo
ELV
Elevance Health Inc
74.87B
QCOM logo
QCOM
Qualcomm Inc
158.82B
VTR logo
VTR
Ventas Inc
39.76B
KDP logo
KDP
Keurig Dr Pepper Inc
39.76B
PKG logo
PKG
Packaging Corp of America
18.95B
BKR logo
BKR
Baker Hughes Co
68.37B
today's stock picks
Intellectia · 74 candidates
Volume: >= 1,000,000Price Change Pct: $1.00 - $10.00List Exchange: XNYS, XNASMoving Average Relationship: PriceAboveMA20Is Index Component: GSPC, NDX
Ticker
Name
Market Cap$
top bottom
KO logo
KO
Coca-Cola Co
329.83B
NUE logo
NUE
Nucor Corp
48.80B
MOH logo
MOH
Molina Healthcare Inc
9.17B
BEN logo
BEN
Franklin Resources Inc
14.12B
UDR logo
UDR
UDR Inc
11.42B
AVB logo
AVB
AvalonBay Communities Inc
23.98B
looking for swing trade stocks today
Intellectia · 71 candidates
Relative Vol: >= 1.80List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Week Price Change Pct: $5.00 - $20.00Is Index Component: GSPCMonthly Average Dollar Volume: >= 3,000,000
Ticker
Name
Market Cap$
top bottom
ON logo
ON
ON Semiconductor Corp
33.65B
DELL logo
DELL
Dell Technologies Inc
131.89B
HPE logo
HPE
Hewlett Packard Enterprise Co
36.90B
BBWI logo
BBWI
Bath & Body Works Inc
4.20B
DHI logo
DHI
D.R. Horton Inc
44.42B
SWK logo
SWK
Stanley Black & Decker Inc
11.67B
most profit stock on Wednesday
Intellectia · 2823 candidates
Market Cap: >= 300.00MRegion: USPrice: >= $1.00List Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
MOVE logo
MOVE
Corvex, Inc
809.51M
CAR logo
CAR
Avis Budget Group Inc
9.01B
ALHC logo
ALHC
Alignment Healthcare Inc
4.43B
ACIU logo
ACIU
AC Immune SA
316.52M
ARMP logo
ARMP
Armata Pharmaceuticals Inc
437.76M
OVID logo
OVID
Ovid Therapeutics Inc
386.63M
stock of the day
Intellectia · 13 candidates
Market Cap: >= 5.00BPrice Change Pct: >= $3.00Relative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
CAR logo
CAR
Avis Budget Group Inc
6.73B
SSL logo
SSL
Sasol Ltd
7.96B
UNH logo
UNH
UnitedHealth Group Inc
255.38B
PSKY logo
PSKY
Paramount Skydance Corp
10.95B
HUM logo
HUM
Humana Inc
21.93B
AAOI logo
AAOI
Applied Optoelectronics Inc
8.35B
stock bearish today
Intellectia · 57 candidates
Market Cap: >= 2.00BPrice Change Pct: <= $-3.00Moving Average Relationship: PriceBelowMA20, PriceBelowMA200
Ticker
Name
Market Cap$
top bottom
BMI logo
BMI
Badger Meter Inc
4.89B
CVNA logo
CVNA
Carvana Co
104.69B
APH logo
APH
Amphenol Corp
198.88B
TLK logo
TLK
Telkom Indonesia (Persero) Tbk PT
23.13B
LPL logo
LPL
LG Display Co Ltd
4.36B
VFC logo
VFC
VF Corp
7.85B
find me stock that have found their bottom
Intellectia · 25 candidates
Weekly Average Turnover: >= 1,000,000Rsi 14: <= 70Moving Average Relationship: PriceCrossAboveMA20Support Resistance Relationship: PriceAroundSupport
Ticker
Name
Market Cap$
top bottom
SCHW logo
SCHW
Charles Schwab Corp
180.87B
UBS logo
UBS
UBS Group AG
148.23B
BCS logo
BCS
Barclays PLC
89.27B
ING logo
ING
ING Groep NV
83.26B
NSC logo
NSC
Norfolk Southern Corp
64.87B
MFC logo
MFC
Manulife Financial Corp
62.58B
stocks with wolfe wave buy signals
Intellectia · 43 candidates
Relative Vol: >= 0.800Rsi 14: 40 - 70Moving Average Relationship: PriceAboveMA20Candlestick Pattern: WhiteCandlestickSupport Resistance Relationship: PriceAroundSupport
Ticker
Name
Market Cap$
top bottom
SCHW logo
SCHW
Charles Schwab Corp
180.87B
UBS logo
UBS
UBS Group AG
148.23B
BCS logo
BCS
Barclays PLC
89.27B
ING logo
ING
ING Groep NV
83.26B
NSC logo
NSC
Norfolk Southern Corp
64.87B
MFC logo
MFC
Manulife Financial Corp
62.58B
suche andere Möglichkeiten bzw. Aktien
Intellectia · 25 candidates
Beta: LowRiskAnalyst Action: UpgradeTarget Price Upside Potential: AbovePriceMonth Price Change Pct: >= $5.00Is Index Component: GSPC
Ticker
Name
Market Cap$
top bottom
CVX logo
CVX
Chevron Corp
335.71B
MRK logo
MRK
Merck & Co Inc
275.78B
TMO logo
TMO
Thermo Fisher Scientific Inc
239.06B
BA logo
BA
Boeing Co
190.08B
HON logo
HON
Honeywell International Inc
139.15B
GD logo
GD
General Dynamics Corp
98.53B
show me stocks with a bullish reversal
Intellectia · 131 candidates
Relative Vol: >= 1.20Rsi 14: 30 - 60Moving Average Relationship: PriceCrossAboveMA20Candlestick Pattern: WhiteCandlestickMonth Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
GOOG logo
GOOG
Alphabet Inc
3.96T
LLY logo
LLY
Eli Lilly and Co
1.02T
SCHW logo
SCHW
Charles Schwab Corp
180.87B
BTI logo
BTI
British American Tobacco plc
125.29B
ARM logo
ARM
Arm Holdings PLC
120.87B
COP logo
COP
ConocoPhillips
120.05B

Whales Holding HUM

S
Slate Path Capital LP
Holding
HUM
+28.92%
3M Return
M
Maple Rock Capital Partners Inc.
Holding
HUM
+16.05%
3M Return
J
Jackson National Asset Management, LLC
Holding
HUM
+15.38%
3M Return
O
Osmosis Investment Management UK Limited
Holding
HUM
+14.25%
3M Return
P
Pzena Investment Management, Inc.
Holding
HUM
+11.93%
3M Return
S
South Dakota Investment Council
Holding
HUM
+11.82%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Humana Inc (HUM) stock price today?

The current price of HUM is 394.62 USD — it has increased 0.45

What is Humana Inc (HUM)'s business?

Humana Inc. provides Humana insurance services and CenterWell health care services. The Company's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.

What is the price predicton of HUM Stock?

Wall Street analysts forecast HUM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HUM is290.39 USD with a low forecast of 231.00 USD and a high forecast of 344.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Humana Inc (HUM)'s revenue for the last quarter?

Humana Inc revenue for the last quarter amounts to 39.65B USD, increased 23.47

What is Humana Inc (HUM)'s earnings per share (EPS) for the last quarter?

Humana Inc. EPS for the last quarter amounts to 9.83 USD, decreased -4.47

How many employees does Humana Inc (HUM). have?

Humana Inc (HUM) has 67060 emplpoyees as of July 08 2026.

What is Humana Inc (HUM) market cap?

Today HUM has the market capitalization of 47.38B USD.